Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

789

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
CholangiocarcinomaGall Bladder Carcinoma
Interventions
DRUG

Gemcitabine

Gemcitabine 1000mg/m2

DRUG

Cisplatin

Cisplatin 25mg/m2

DRUG

Capecitabine

Capecitabine 1250mg/m2

Trial Locations (67)

1030

Kaiser-Franz-Josef Hospital, Vienna

6008

St. John of God, Subiaco

6150

Fiona Stanley Hospital Perth, Murdoch

20246

University Medical Center Hamburg-Eppendorf, Hamburg

35128

Istituto Oncologico Veneto IRCCS, Padua

56126

Azienda Ospedaliero Medica 2 Universitaria, Pisa

Unknown

Bankstown Hospital, Bankstown

Nepean Hospital Cancer Care, Kingswood

St. George Hospital, Kogarah

Prince of Wales Hospital, Randwick

Calvary Mater Newcastle, Waratah

Townsville Hospital, Douglas

Royal Brisbane and Women's Hospital, Herston

Princess Alexandra Hospital, Woolloongabba

Flinders Medical Centre, Bedford Park

Sir Charles Gairdner Hospital, Nedlands

Vejle Hospital, Vejle

University Medical Center Aachen, Aachen

Charite Berlin, Berlin

University Medical Center Carl Gustav Carus, Dresden

University Medical Center Essen, Essen

Klinikum Esslingen, Esslingen am Neckar

University of Frankfurt, Frankfurt

University Medical Center Freiburg, Freiburg im Breisgau

University of Hannover, Hanover

University of Heidelberg, Heidelberg

University of Saarland, Homburg

University Medical Center Jena, Jena

Johannes Gutenberg University of Mainz, Mainz

University of Mannheim, Mannheim

University of Munich Grosshadern, Munich

University of Regensburg, Regensburg

University Medical Center Tuebingen, Tübingen

University of Ulm, Ulm

University Medical Center, Würzburg

Fondazione Policlinico Gemelli, Roma, Rome

Istituto Nazionale dei Tumori, Milan

Ospedale San Raffaele, Milan

Academic Medical Center, Amsterdam

University Medical Center, Maastricht

Erasmus Medisch Centrum, Rotterdam

Universitair Medisch Centrum Utrecht, Utrecht

Auckland Hospital, Auckland

Hampshire Hospitals NHS Foundation Trust, Basingstoke

Queen Elizabeth Hospital Birmingham, Birmingham

Royal Bournemouth Hospital, Bournemouth

Bristol Haematology and Oncology Centre, Bristol

Addenbrooke's Hospital Cambridge, Cambridge

Velindre Hospital Cardiff, Cardiff

Western General Hospital Edinburgh, Edinburgh

Beatson West of Scotland Cancer Centre Glasgow, Glasgow

James Paget University Hospitals, Great Yarmouth

Royal Surrey County Hospital Guildford, Guildford

Princess Alexandra Hospital, Harlow

Huddersfield Royal Infirmary, Huddersfield

Guy's and St Thomas's Hospital London, London

Hammersmith Hospital London, London

Royal Free Hospital London, London

University College London Hospital, London

Maidstone Hospital, Maidstone

Christie Hospital Manchester, Manchester

Clatterbridge Cancer Centre, Metropolitan Borough of Wirral

Nottingham University Hospitals NHS Trust, Nottingham

Churchill Hospital Oxford, Oxford

Derriford Hospital Plymouth, Plymouth

Weston Park Hospital Sheffield, Sheffield

Southampton General Hospital, Southampton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Deutsche Krebshilfe e.V., Bonn (Germany)

OTHER

collaborator

Cancer Research UK

OTHER

collaborator

Australasian Gastro-Intestinal Trials Group

NETWORK

collaborator

Dutch Cancer Society

OTHER

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER